Search

everythinglearnresearchcommunity

for

Search:↓

Higher light doses cause more damage to hair follicles, predicting better hair removal results.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Hair cortisol is a reliable marker of long-term cortisol levels and is linked to daytime saliva cortisol but not morning levels.

Minoxidil and vitamin E may help improve nail growth and health.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

A rare scalp infection in a 66-year-old woman was successfully treated, leading to full hair regrowth.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

The book provides detailed information on natural ingredients in beauty products and emphasizes the need for more human trials to confirm their effectiveness.

OMICS International aimed to make scientific research freely accessible to all.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Vorasidenib can cause unusual hair growth.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Severe alopecia areata patients have a low chance of spontaneous hair regrowth.

Oral finasteride seems more effective for hair loss in postmenopausal women, but more research is needed.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

More effective treatments are needed for severe alopecia areata.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.